Cutaneous Leishmaniasis in High‐Altitude: A Case Report From Nepal [PDF]
Clinical Case ReportsLeishmaniasis is a parasitic infection caused by Leishmania and spread by the bite of a sandfly, most commonly Phlebotomus. Among the three subtypes of Leishmaniasis, cutaneous leishmaniasis is the most common form.
Eliz Aryal +5 more
doaj +2 more sources
Spiny Hyperkeratosis-Like Follicular Mycosis Fungoides: A Case Report [PDF]
Middle East Journal of Cancer, 2023 Folliculotropic mycosis fungoides (FMF) is a rare variant of cutaneous T-cell lymphoma which is categorized as a separate entity. In histopathology, malignant lymphocytes selectively surround and infiltrate hair follicles.
Shatila Torabi +3 more
doaj +1 more source
Evaluation of clinical risk factors for systemic antimony treatment failure in patients with acute cutaneous leishmaniasis referred to dermatology clinics of Mashhad University of Medical Sciences, Iran [PDF]
Journal of Kerman University of Medical Sciences, 2023 Background: Systemic or topical form of pentavalent antimony compounds such as Meglumine Antimoniate (MA) are used as Standard treatment for cutaneous leishmaniasis (CL).
Yalda Nahidi +5 more
doaj +1 more source
Auricular Sebaceous Carcinoma, Report of a Rare Case [PDF]
Middle East Journal of Cancer, 2023 Sebaceous carcinoma is a rare and invasive tumor that originates from the Zeis and Meibomian glands around the eyes as well as in sebaceous glands in other head and neck areas and less commonly on the trunk.
Shatila Torabi +2 more
doaj +1 more source
Translational Pharmacokinetic-Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI-6148 for the Treatment of Cutaneous Leishmaniasis. [PDF]
Clin Transl SciABSTRACT Cutaneous leishmaniasis is a neglected tropical disease with only one oral treatment option. DNDI‐6148 is an orally bioavailable compound with potent antiparasitic activity in preclinical studies. Establishing skin target‐site pharmacokinetic/pharmacodynamic (PK/PD) relationships is essential to enable its clinical development.
Henninger RH +7 more
europepmc +2 more sources
Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments
American Journal of Clinical Dermatology, 2022 This review is an update of an earlier narrative review published in 2015 on developments in the clinical management of cutaneous leishmaniasis (CL) including diagnosis, treatment, prevention and control measurements.
H. D. de Vries, Henk Schallig
semanticscholar +1 more source
Frontiers in Cellular and Infection Microbiology, 2021 Leishmaniasis is a neglected tropical disease that affects 12 million people worldwide. The disease has high morbidity and mortality rates and is prevalent in over 80 countries, leaving more than 300 million people at risk of infection.
Greta Volpedo +5 more
semanticscholar +1 more source
An introduction to application of platelet rich plasma (PRP) in skin rejuvenation [PDF]
Reviews in Clinical Medicine, 2014 Platelet-rich plasma (PRP) is an autologous concentration of human platelets contained in a small volume of plasma characterized by haemostatic and tissue repairing effects.
Mahnaz Banihashemi, Solmaz Nakhaeizadeh
doaj +3 more sources
Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review
PLoS Neglected Tropical Diseases, 2021 Cutaneous leishmaniasis has been endemic since decades. Millions of cases are reported worldwide specially in developing and underdeveloped countries. There are 2 major types of cutaneous leishmaniasis based on the causating species found in different ...
M. Azim +4 more
semanticscholar +1 more source
Cutaneous and Mucocutaneous Leishmaniasis.
Actas Dermo-Sifiliográficas, 2021 Leishmaniasis is a chronic disease caused by flagellate protozoa of the genus Leishmania. It is a global disease, but most cases are seen in South America, the Mediterranean, and some areas of Asia and Africa.
I. Abadías-Granado +5 more
semanticscholar +2 more sources